While the National Pharmaceutical Pricing Authority (NPPA) recent trade margin rationalisation has reduced the prices of several anti-cancer medicines, experts say India needs comprehensive cancer care, stronger price regulation, greater transparency and expanded public healthcare provision to protect patients from catastrophic expenditure.Are lower MRPs on cancer drugs translating into affordable care? Here, we discuss.Guests: Dr. Indu Bhushan, bureaucrat, economist and the first CEO of Ayushman Bharat; Mr. K.M. Gopakumar, legal advisor, senior researcher and public health expert.Host: Bindu Shajan PerappadanProducer: Jude Francis WestonFor more episodes of In Focus: Published - November 05, 2026 05:54 pm IST
Are lower MRPs on cancer drugs translating into affordable care? | In Focus Podcast
Full Article
Original Source
Read the full article at Thehindu →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.